Future Price to Earnings: Cerevel Corp (CERE)

Symbol and logo of brand Cerevel Therapeutics, Inc. (CERE)

After assessing the change in the future P/E ratio of Cerevel Therapeutics (CERE) on GURU.Markets, we find that 0.00 reflects the most recent value of the metric. This price action confirms the success of the Cerevel acquisition by the AbbVie behemoth, driven by the transparency of its neurological drugs. However, geopolitical conflicts and sanctions are currently hindering international research and component logistics. Meanwhile, the market valuation already prices in asset synergies, anticipating the medium-term launch of schizophrenia treatments.

CERE - Cerevel Therapeutics Inc Projected Price to Earnings Ratio over the range 07/04/2022 - 08/10/2024

Summary analytical data breakdowns for cerevel.com (CERE)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
General company analysis:Cerevel CERE
Brand item of Cerevel Therapeutics

The forward P/E ratio relates the current market value of the business to expected earnings, allowing for an assessment of the premium paid for future cash flow. By analyzing the forward price-to-earnings ratio of Cerevel Therapeutics (CERE), an investor determines the balance between the cost of capital and growth potential, which for Cerevel Therapeutics (CERE) is supported by unique patents in neurodegenerative disease therapy and robust R&D funding.

Direct competitors

Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Forward P/E Multiple RGC (Regencell Bioscience Ltd)|Market Cap to Projected Earnings axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Future Price to Earnings|Supernus Corp - Future Price to Earnings Multiple|Projected Price to Earnings CPRX|Denali Therapeutics Inc. (DNLI) - Market Cap to Projected Earnings|Projected Price to Earnings HRMY (Harmony Corp)|BHVN - Projected Price to Earnings Ratio|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Future Price to Earnings Multiple TRVI|PRAX - Future Price to Earnings|Market Cap to Projected Earnings Anavex Life Sciences AVXL|CBLL: Forward P/E Multiple|Projected Price to Earnings Prothena Corporation PLC|ALEC (alector.com) - Forward P/E Multiple|Projected Price to Earnings Annexon, Inc. (ANNX)|Future Price to Earnings Omeros Corporation (OMER)|Neurogene Inc. - Price to Future Earnings Ratio|acimmune.com - Projected Price to Earnings|Forward P/E Multiple Voyager Therapeutics Inc VYGR|NMRA - Future Price to Earnings|Forward Price to Earnings Multiple Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Future Price to Earnings|Price to Future Earnings Ratio ACOG|Future Price to Earnings Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings SAVA (Cassava)|Market Cap to Projected Earnings Assertio Therapeutics|Coya Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forward P/E Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Projected Price to Earnings|CRVO (CervoMed, Inc.) - Projected Price to Earnings|Projected Price to Earnings Alterity Therapeutics Ltd|Future Price to Earnings Clene Inc.|PepGen Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings JUNS (Jupiter Neurosciences Inc)|Future Price to Earnings RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Projected Price to Earnings|Market Cap to Projected Earnings Grace Tx (GRCE)|fireflyneuro.com - Forward P/E Multiple|Klotho Neurosciences (KLTO) - Projected Price to Earnings|NeuroSense Therapeutics, Ltd. (NRSN) - Future Price to Earnings|Price to Expected Earnings Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forward P/E Multiple|NRXS: Future Price to Earnings Multiple|Forward P/E Multiple HSDT|Forward P/E Multiple Passage Bio Inc. (PASG)|Future Price to Earnings bionomics.com.au NEUP|Forward P/E Multiple Minerva Neurosciences Inc NERV|ATHA: Projected Price to Earnings|ADXN (Addex Therapeutics, Ltd.) - Price to Future Earnings Ratio|Alzamend Neuro Inc. (ALZN) - Future Price to Earnings|Cyclerion - Future Price to Earnings Multiple|Future Price to Earnings protagenic.com|Pasithea Therapeutics - Price to Expected Earnings Ratio|Projected Price to Earnings CRGT (Cortigent, Inc.)|Avenue Therapeutics - Price to Future Earnings Ratio|Future Price to Earnings Brainstorm Cell BCLI|Forward P/E Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forward P/E Multiple|eliemtx.com - Market Cap to Future Earnings Ratio|Intra-Cellular Therapies (ITCI) - Future Price to Earnings|LBPH (Longboard) - Future Price to Earnings|MRNS (marinuspharma.com) - Forward P/E Multiple|Projected Price to Earnings Ratio NKGen Biotech NKGN|Future Price to Earnings NeuroBo Pharma (NRBO)|Market Cap to Future Earnings Ratio SAGE|Synaptogenix, Inc. - Projected Price to Earnings|TRVN: Price to Future Earnings Ratio|VIGL - Future Price to Earnings|Future Price to Earnings Multiple WENA (Anew Medical, Inc.)